Pura Vida Investments’s Clearside Biomedical CLSD Stock Holding History

Pura Vida Investments’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,433	Closed	-$939K	–	249
2021 Q3	$939K	Buy	+10,433	New	+$921K	0.03%	224

Other funds holding CLSD

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pura Vida Investments's CLSD Position: Q4 2018 in Review

Pura Vida Investments sold out of Clearside Biomedical (CLSD) in Q4 2018, closing a stake of 3,375 shares — an estimated $311K sold.

Pura Vida Investments first reported a position in CLSD in Q1 2018 and held it in 2 quarters. The position peaked at $725K in Q1 2018. 69 funds tracked by Wall St. Rank hold CLSD as of Q4 2018.

Pura Vida Investments reported no remaining Clearside Biomedical position as of Q4 2018 after selling out during the quarter.
Pura Vida Investments sold 3,375 Clearside Biomedical shares in Q4 2018, an estimated $311K.
Pura Vida Investments first reported a position in Clearside Biomedical in Q1 2018 and held it in 2 quarters.
Pura Vida Investments's Clearside Biomedical position peaked at $725K in Q1 2018.
69 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2018.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.